Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (5): 915-920. doi: 10.19723/j.issn.1671-167X.2021.05.017
Previous Articles Next Articles
ZHANG Mei-xiang1,SHI Wen-zhi2,LIU Jian-xin1,WANG Chun-jian1,LI Yan1,WANG Wei1,JIANG Bin1,△()
CLC Number:
[1] | Liedtke M, Ayton PM, Somervaille TCP, et al. Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6 [J]. Blood, 2010, 116(1):63-70. |
[2] |
Meyer C, Burmeister T, Gröger D, et al. The MLL recombinome of acute leukemias in 2017 [J]. Leukemia, 2018, 32(2):273-284.
doi: 10.1038/leu.2017.213 pmid: 28701730 |
[3] | 刘艳荣, 于弘, 常艳, 等. 四色荧光标记抗体在白血病免疫分型中的应用及意义 [J]. 中国实验血液学杂志, 2002, 10(5):423-427. |
[4] | 主鸿鹄, 刘艳荣, 秦亚溱, 等. 实时定量PCR检测46例初诊急性早幼粒细胞白血病患者PML/RARα mRNA的分子表达 [J]. 中国实验血液学杂志, 2007, 15(1):1-5. |
[5] | 沈悌, 赵永强. 血液病诊断及疗效标准 [M]. 第4版. 北京: 科学出版社, 2018: 91-95. |
[6] | Jaffe ES, Harris NL, Stein H, et al. World Health Organization of tumors pathology & genetics, tumors of haematopoietic and lymphoid tissues [M]. Lyon: IARC Press, 2001: 86-87. |
[7] |
Pigneux A, Labopin M, Maertens J, et al. Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML) [J]. Leukemia, 2015, 29(12):2375-2381.
doi: 10.1038/leu.2015.143 pmid: 26082270 |
[8] |
Mrózek K, Heinonen K, Lawrence D, et al. Adult patients with de novo acute myeloid leukemia and t (9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study [J]. Blood, 1997, 90(11):4532-4538.
pmid: 9373264 |
[9] |
Blum W, Mrózek K, Ruppert AS, et al. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature [J]. Cancer, 2004, 101(6):1420-1427.
doi: 10.1002/cncr.v101:6 |
[10] |
Martineau M, Berger R, Lillington DM, et al. The t (6; 11)(q27; q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases [J]. Leukemia, 1998, 12(5):788-791.
pmid: 9593282 |
[11] |
Gröschel S, Schlenk RF, Engelmann J, et al. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group [J]. J Clin Oncol, 2013, 31(1):95-103.
doi: 10.1200/JCO.2011.41.5505 pmid: 23008312 |
[12] |
Manara E, Baron E, Tregnago C, et al. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia [J]. Blood, 2014, 124(2):263-272.
doi: 10.1182/blood-2013-09-525741 pmid: 24695851 |
[13] |
Neff T, Armstrong SA. Recent progress toward epigenetic therapies: the example of mixed lineage leukemia [J]. Blood, 2013, 121(24):4847-4853.
doi: 10.1182/blood-2013-02-474833 |
[14] |
Krauter J, Wagner K, Schäfer I, et al. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup [J]. J Clin Oncol, 2009, 27(18):3000-3006.
doi: 10.1200/JCO.2008.16.7981 pmid: 19380453 |
[15] |
Tamai H, Yamaguchi H, Takahashi S, et al. Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT in the first CR [J]. Bone Marrow Transplant, 2008, 42(8):553-554.
doi: 10.1038/bmt.2008.200 |
[16] |
Mitterbauer G, Zimmer C, Pirc-Danoewinata H, et al. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction [J]. Br J Haematol, 2000, 109(3):622-628.
doi: 10.1046/j.1365-2141.2000.02076.x |
[1] | Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588. |
[2] | Shuai LIU,Lei LIU,Zhuo LIU,Fan ZHANG,Lulin MA,Xiaojun TIAN,Xiaofei HOU,Guoliang WANG,Lei ZHAO,Shudong ZHANG. Clinical treatment and prognosis of adrenocortical carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 624-630. |
[3] | Le YU,Shaohui DENG,Fan ZHANG,Ye YAN,Jianfei YE,Shudong ZHANG. Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 661-666. |
[4] | Zezhen ZHOU,Shaohui DENG,Ye YAN,Fan ZHANG,Yichang HAO,Liyuan GE,Hongxian ZHANG,Guoliang WANG,Shudong ZHANG. Predicting the 3-year tumor-specific survival in patients with T3a non-metastatic renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 673-679. |
[5] | Yangyi FANG,Qiang LI,Zhigao HUANG,Min LU,Kai HONG,Shudong ZHANG. Well-differentiated papillary mesothelial tumour of the tunica vaginalis: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 741-744. |
[6] | Yuanyuan ZENG,Yun XIE,Daonan CHEN,Ruilan WANG. Related factors of euthyroid sick syndrome in patients with sepsis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 526-532. |
[7] | Jian-bin LI,Meng-na LYU,Qiang CHI,Yi-lin PENG,Peng-cheng LIU,Rui WU. Early prediction of severe COVID-19 in patients with Sjögren’s syndrome [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1007-1012. |
[8] | Huan-rui LIU,Xiang PENG,Sen-lin LI,Xin GOU. Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 793-801. |
[9] | Zi-xuan XUE,Shi-ying TANG,Min QIU,Cheng LIU,Xiao-jun TIAN,Min LU,Jing-han DONG,Lu-lin MA,Shu-dong ZHANG. Clinicopathologic features and prognosis of young renal tumors with tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811. |
[10] | Han LU,Jian-yun ZHANG,Rong YANG,Le XU,Qing-xiang LI,Yu-xing GUO,Chuan-bin GUO. Clinical factors affecting the prognosis of lower gingival squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 702-707. |
[11] | Yun-fei SHI,Hao-jie WANG,Wei-ping LIU,Lan MI,Meng-ping LONG,Yan-fei LIU,Yu-mei LAI,Li-xin ZHOU,Xin-ting DIAO,Xiang-hong LI. Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 521-529. |
[12] | Xiao-juan ZHU,Hong ZHANG,Shuang ZHANG,Dong LI,Xin LI,Ling XU,Ting LI. Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 243-253. |
[13] | Yu-mei LAI,Zhong-wu LI,Huan LI,Yan WU,Yun-fei SHI,Li-xin ZHOU,Yu-tong LOU,Chuan-liang CUI. Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 262-269. |
[14] | Qi SHEN,Yi-xiao LIU,Qun HE. Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 276-282. |
[15] | Wen-han BAO,Wen TANG. Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 124-132. |
|